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Antigenic anatomy of the kidney and renal graft rejection. W.
M. Baldwin, F. H. J. Claas, L.A. van Es, G. G. Persijn, andf.
J. van Rood. Departments of Nephrology and Immuno-
Haematology, University Hospital, Leiden, The Netherlands.
Some patients who reject renal grafts within a short time (< 50
days) have circulating antibodies to antigens that are present on
endothelium and monocytes (EM antigens) and are absent on
platelets and lymphocytes. Patients with good graft function do
not have EM antibodies (EMAb). To evaluate the role of EM
antigens in transplantation, we have investigated the following
questions: (1) what other antigens are on the renal endothelium?
(2) Why do only some patients form EMAb? A panel of 25 pre-
transplant renal biopsies were stained by indirect immuno-
fluorescence. Monoclonal antibodies to f32 microglobulin, DR (P
23.30), and HLA-ABC glycoproteins (provided by W. Bodmer)
stained the endothelium of glomeruli, arteries, and peritubular
capillaries. Monoclonal antibodies to HLA-A2 and B-7 specific-
ities gave faint or no staining. Of 17 cytotoxic alloimmune HLA-
typing sera (A-l,2,3,28; B-7,8,12,15,27,40), three B-7 sera react-
ed with endothelium. No false-positives occurred with B-7 sera,
but 11 to 75% false-negatives were observed. Platelet absorption
removed this activity. Of 7 alloimmune DR sera samples (DRW
1,2,3,4,7,8), 3 reacted with endothelium. No false-positives oc-
curred, but there was 30 to 70% false-negatives. Of 18 typing sera
directed to LB 12,13,14, and MT2 (a second antigen system on
B-cells), 11 sera samples gave frequent, moderately strong stain-
ing of renal endothelium. Whether these reactions are due to B-
cell antigens on endothelium or contaminating EMAb is under
study. Staining for EM antigens was consistently much stronger
than that for HLA. Absorption studies are necessary to confirm
this apparent difference in antigen concentration. There appears
to be no correlation between the formation of EMAb in acute
rejectors and the number of HLA-A + B mismatches with the
renal graft, but there is for DR mismatches (6 of 8 patients with
EMAb had 2 DR mismatches vs. 3 of 11 without EMAb). In
some patients, EMAb formation may be related to the lack of
pretransplant blood transfusions because 4 of 16 patients with
EMAb had no transfusions whereas all 19 patients without
EMAb had transfusions. Thus, DR antigens may stimulate help-
er T-cells, and EM antigens present the target for antibody re-
sponses in renal graft rejection. Preexposure to monocytes in
blood transfusions may inhibit the reaction to EM antigens.
Experimental induction of systemic lupus erythematosus: Pref-
erential triggering of SLE-typical auto-reactive B cells. E. Gleich-
mann. Central Laboratory Blood Transfusion Service, Amster-
dam, The Netherlands. No abstract was received. Will be pub-
lished elsewhere.
Membranous glomerulopathy in captopril-treated patients. S. J.
Hoorntje, J. J. Weeing, C. Kallenberg, P. J. Hoedemaeker, J.
M. Donker. Pathological Anatomical Laboratory University
Groningen, The Netherlands. No abstract was received. Will be
published elsewhere.
Circulating IgA-containing immune complexes in Henoch-
Schönlein purpura. R. H. Kauffmann, W. A. Herrmann, C. J. L.
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M. MeUer, M. R. Daha, and L. A. van Es. Department of Neph-
rology, Dermatology and Pathology, University Hospital, Lei-
den, The Netherlands. In Henoch-Schönlein purpura, immune
complexes (IC) in inflamed vessel walls characteristically con-
tain IgA. To determine whether IgA is also the predominant class
of immunoglobulin in circulating IC, we compared the results of
three immune complex assays with specificities for different
classes of immunoglobulins in 49 patients (40 children and 9
adults) with Henoch-Schönlein purpura. Circulating IgA-con-
taming IC detected by their reactivity with a low-avidity anti-IgA
antibody were found in 37 of the 49 patients. The presence of
these IC corresponded closely with the simultaneous demonstra-
tion of IgA in cutaneous vessel walls. Longitudinal studies
showed that high levels of IgA-containing IC were only found in
the initial phase of the disease. Later in the course, they were not
found in children with acute disease and were detected at lower
levels in patients with persistent signs of renal involvement. IgA-
containing IC were not found in patients with acute glomerulone-
phritis, viral exanthematous diseases, or bacterial infections. IC
with bound complement breakdown products were demon-
strated by binding to conglutinin. IgA was found in these IC in
19 patients, IgU in 21, and 1gM in 13. Conglutinin-binding IC
occurred later in the course of the disease and also after remis-
sion. Moreover, the immunoglobulins in these IC were not re-
lated to the immunoglobulin class in the deposits. Clq-binding IC
were only found in two patients. The levels of C3d were raised in
40 patients. These findings show that circulating IC that contain
IgA may be directly involved in the pathogenesis of vasculitis in
Henoch-SchOnlein purpura, whereas complement-reacted IC
containing other immunoglobulin classes may appear in the cir-
culation in a later phase.
Immunoregulation and antinuclear antibodies in mercury-in-
duced immune complex glomerulopathy in the rat. J. J. Weening,
W. W. Bakker, and P. J. Hoedemaeker. Department of Patholo-
gy, State University of Groningen, Groningen, The Netherlands.
Chronic administration of mercuric chloride to the PVGIc rat in-
duces a membranous and mesangial immune complex glomerulo-
pathy associated with circulating antinuclear antibodies (ANA).
To determine the origin of the ANA response, we investigated
certain features of lymphocyte function and immunoregulation in
this model. First, general T-cell responsiveness was assessed by
measuring in vitro PHA stimulation of lymphocytes from mer-
cury-diseased rats. In addition, the in vitro effect of mercuric
chloride on PHA stimulation of normal rat lymphocytes was de-
termined. The results showed a decreased mitogenic stimulation
of lymphocytes from mercury-diseased animals as compared
with that of lymphocytes from control animals. Furthermore, a
dose-dependent decrease of mitogenic stimulation of normal rat
lymphocytes was found when cultured in the presence of mer-
curic chloride. Second, concanavalin A (con A) -activated sup-
pressor T-cell function was measured in lymphocytes from mer-
cury-diseased and control animals. Therefore, lymphocytes were
incubated with con A for 48 hours, washed with a-methyl-n-
mannoside and then cocultured with lymphocytes from synge-
neic animals in the presence of 5 of con A. As a control, non-
con A preincubated lymphocytes from mercury-diseased and
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control rats were cocultured with syngeneic lymphocytes. After
96 hours, the suppressive effect of con A and non-con A pre-
incubated lymphocytes on the mitogenic stimulation of the syn-
geneic test lymphocytes was calculated from tritium-labeled
thymidin incorporation. Con A-activated suppression was found
to be significantly decreased in lymphocytes from mercury-dis-
eased rats as compared with lymphocytes of control animals. Fi-
nally, the effect of neonatal and adult thymectomy was studied
on the mercury-induced glomerulopathy and ANA response.
Neonatal thymectomy was found to accelerate the ANA re-
sponse and the glomerular immune aggregate formation consid-
erably, whereas adult thymectomy had no effect on the course of
the disease. From these results, it is concluded that mercury-
induced ANA and glomerulopathy are associated with a distur-
bance of regulatory T-cell functions and that this disturbance of
immunoregulation may be of pathogenetic significance, because
neonatal thymectomy was found to accelerate the disease.
Treatment and outcome of severe glomerulonephritis in systemic
vasculitis (M. Wegener). J. M. Wilmink, A. G. Balk, S. Surachno,
andJ. H. ten Veen. Departments of Nephrology and Pathology,
University Hospital Wilhelmina Gasthuis, Amsterdam. In the
period 1970—1978, 35 out of 1162 renal biopsies from two labora-
tories revealed total diffuse extracapillary proliferative glomeru-
lonephritis (DEPG). Twenty of these accompanied systemic vas-
culitis, especially Wegener's disease. As this disease seems to be
responsive to combined corticosteroids and cytotoxic drugs, we
studied 11 of these patients who had systemic vasculitis and pre-
dominantly severe renal disease and who were treated with this
drug regimen. Their ages ranged from 17 to 69 years (mean, 48
years), and only two of them were females. Initial treatment con-
sisted of prednison (Ito 3 mg), and either azathioprine (2 to 4mg)
or cyclophosphamide (2 to 3 mg) (all per kg of body wt); further-
more, short courses of actinomycin C or D were used. After a
prodromal stage (range, Ito 15 months; mean, 4.5 months), renal
disease suddenly developed leading to oligoanuria in 7 patients,
necessitating hemodialysis treatment for 2 to 6 weeks. Renal
biopsy revealed DEPG in 8 patients and local to focal glomerulo-
nephritis in another 2. Immunofluorescence studies did not re-
veal a granular pattern, neither a linear pattern of complement
nor immunoglobulins. Eight patients recovered from their illness
with partial to almost complete recovery of renal function. Three
of them (followup of less than 2 years) are still under treatment.
Five patients showed prolonged survival (range, 52 to 156
months; mean, 89 months) without therapy. One patient, how-
ever, relapsed without renal disease and is on therapy again. One
patient died from bronchialcarcinoma, one patient suffered hem-
orrhagic cystitis, and one developed leukopenia and erythro-
leukemia. In II patients, 14 infections were noticed leading to
death in 3 patients in the acute phase of the illness. In three pa-
tients, the addition of cytotoxic agents to their drug regimen (cor-
ticosteroids in 1 and combined corticosteroids and cytostatics in
2 others) resulted in further improvement of renal function. Con-
clusions. (1) Severe renal involvement in systemic vasculitis for
the greater part can be corrected after intensive long-term treat-
ment with corticosteroids and cytotoxic agents. (2) Frequently,
infections are observed; some are lethal. (3) Followup of patients
off therapy is necessary in order to trace relapses in time, as well
as complications from cytotoxic agents (for example, pan-
cytopenia, leukemia, hemorrhagic cystitis).
